🌎 Ambarella Downgraded, Galapagos Initiated, argenx Initiated and more...

Ratings changes for Sportsman's Warehouse, MorphoSys, Microsoft, Titan Machinery, NeuroMetrix, Ambarella, DocuSign and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.

VIEW MY PORTFOLIO

May 31st, 2023

The Graphite Shortage Story You're Not Being Told (ad) Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. Here's how investors can play it Today's Top Stories 3 Late-Season Earnings Plays for Mid-Cap Traders Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy URGENT: Build Wealth 10x Faster By Doing This (Darwin) 3 Stocks Worth Buying at 52-Week Lows German inflation slows to 6.1% in May, though food prices are still surging Don't Worry; Sportsman's Warehouse Will Get Cheaper  Stock market today: Wall Street slumps with markets worldwide Buy THIS stock before Taiwan is attacked (Behind the Markets) Trinseo's Dip, Has Something Changed Or Is It Just A Down Cycle China factory activity slows, adding to economic strains The Most Upgraded Stocks From The Q1 Earnings Season How major US stock indexes fared Tuesday 5/30/2023 Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings Company Profiles Dividend Declarations Earnings Announcements Headlines Insider Trades Insider Buying Stocks Insider Selling Stocks Get Five Stocks Free Free ebook: Reveal Key Stock Market Secrets (ad) Learn the 6 greatest stock market myths - 3 rules to pick the right stocks - Powerful techniques to accurately value stocks – Insights on stock valuation and stock market cycles – Secrets revealed on how to successfully manage your portfolio and much more… Download Your Free eBook Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades Akebia Therapeutics (NASDAQ:AKBA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.The current price is $1.10. Avis Budget Group (NASDAQ:CAR) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $263.00 price target on the stock, up previously from $239.00. This represents a 54.8% upside from the current price of $169.90. Carisma Therapeutics (NASDAQ:CARM) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $7.00 price target on the stock. This represents a 25.4% upside from the current price of $5.58. Centerra Gold (NYSE:CGAU) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating.The current price is $5.93. Centerra Gold (NYSE:CGAU) was upgraded by analysts at TD Securities from a "hold" rating to a "buy" rating.The current price is $5.93. Chevron (NYSE:CVX) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $170.00 price target on the stock, up previously from $161.00. This represents a 12.1% upside from the current price of $151.67. J D Wetherspoon (OTCMKTS:JDWPF) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $9.00. Lenovo Group (OTCMKTS:LNVGY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating.The current price is $18.80. Mitchells & Butlers (OTCMKTS:MBPFF) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $2.72. Q2 (NYSE:QTWO) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $36.00 price target on the stock. This represents a 26.2% upside from the current price of $28.53. Xylem (NYSE:XYL) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $135.00 price target on the stock, up previously from $122.00. This represents a 34.5% upside from the current price of $100.34. View today's most recent analysts' upgrades at MarketBeat.com U.S. Loses to China in Shocking WAR GAMES (ad) === BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>> Get the name of the stock here Analysts' Downgrades PT Merdeka Copper Gold Tbk (OTCMKTS:PMCGF) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $0.20. TIS (OTCMKTS:TISNF) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating.The current price is $27.20. Tele2 AB (publ) (OTCMKTS:TLTZY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $4.62. View today's most recent analysts' downgrades at MarketBeat.com Why did Biden repeal Trump's Executive Order?! (ad) " Why did Biden repeal Trump's Executive Order?! Within 10 days of taking office, President Trump signed "Executive Order 13771" in an effort to win the battle for what 60 minutes said could be "the most consequential discovery in biomedicine this century." So why did Biden repeal this? Click here to learn more >>> " Click here to learn more Analysts' New Coverage ACNB (NASDAQ:ACNB) is now covered by analysts at Hovde Group. They set an "outperform" rating and a $36.00 price target on the stock. This represents a 22.4% upside from the current price of $29.40. argenx (NASDAQ:ARGX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $480.00 price target on the stock. This represents a 23.2% upside from the current price of $389.58. BRC (NYSE:BRCC) is now covered by analysts at Needham & Company LLC. They set a "hold" rating on the stock. They noted that the move was a valuation call.The current price is $5.33. Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $128.00 price target on the stock. This represents a 37.3% upside from the current price of $93.22. Cedar Fair (NYSE:FUN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $50.00 price target on the stock. This represents a 14.0% upside from the current price of $43.87. Galapagos (NASDAQ:GLPG) is now covered by analysts at UBS Group AG. They set a "neutral" rating on the stock.The current price is $41.28. Genmab A/S (NASDAQ:GMAB) is now covered by analysts at UBS Group AG. They set a "neutral" rating on the stock.The current price is $39.14. Hillman Solutions (NASDAQ:HLMN) is now covered by analysts at Imperial Capital. They set an "outperform" rating and a $10.25 price target on the stock. This represents a 28.6% upside from the current price of $7.97. Inventiva (NASDAQ:IVA) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $11.00 price target on the stock. This represents a 203.9% upside from the current price of $3.62. MDxHealth (NASDAQ:MDXH) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $7.00 price target on the stock. This represents a 91.8% upside from the current price of $3.65. MorphoSys (NASDAQ:MOR) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.The current price is $6.39. Near Intelligence (NASDAQ:NIR) is now covered by analysts at Northland Securities. They set an "outperform" rating on the stock.The current price is $1.77. Nevro (NYSE:NVRO) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 45.6% upside from the current price of $27.47. PROCEPT BioRobotics (NASDAQ:PRCT) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $32.58. Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating on the stock.The current price is $50.00. SeaWorld Entertainment (NYSE:SEAS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $75.00 price target on the stock. This represents a 34.9% upside from the current price of $55.61. Saga Communications (NASDAQ:SGA) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $27.00 price target on the stock. This represents a 36.6% upside from the current price of $19.76. Six Flags Entertainment (NYSE:SIX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $26.00 price target on the stock. This represents a 3.5% upside from the current price of $25.13. Sovos Brands (NASDAQ:SOVO) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $22.50 price target on the stock. This represents a 19.6% upside from the current price of $18.81. Terns Pharmaceuticals (NASDAQ:TERN) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $23.00 price target on the stock. This represents a 115.2% upside from the current price of $10.69. UCB (OTCMKTS:UCBJF) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.The current price is $87.10. UCB (OTCMKTS:UCBJY) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.The current price is $42.52. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: BREAKING: Tiny biotech successfully treats blindness